Scarica l'app Stockscreener
21.19
0.05%
-0.010
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$21.20
Aprire:
$21.39
Volume 24 ore:
1.00M
Relative Volume:
1.53
Capitalizzazione di mercato:
$1.03B
Reddito:
$458.69M
Utile/perdita netta:
$11.68M
Rapporto P/E:
88.22
EPS:
0.2402
Flusso di cassa netto:
$14.58M
1 W Prestazione:
+2.86%
1M Prestazione:
-10.82%
6M Prestazione:
-55.06%
1 anno Prestazione:
-28.65%
Intervallo 1D:
$20.83
$21.66
Intervallo di 1 settimana:
$19.88
$22.12
Portata 52W:
$19.16
$48.25
Artivion Inc Stock (AORT) Company Profile
Nome
Artivion Inc
Settore
Industria
Telefono
(770) 419-3355
Indirizzo
1655 ROBERTS BOULEVARD N W, KENNESAW
Compare AORT vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AORT
Artivion Inc
|
21.19 | 1.03B | 458.69M | 11.68M | 14.58M | 0.2402 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-10 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2025-08-13 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2025-06-17 | Iniziato | Canaccord Genuity | Buy |
| 2024-10-23 | Iniziato | JMP Securities | Mkt Outperform |
| 2022-09-27 | Reiterato | Lake Street | Buy |
| 2022-08-08 | Iniziato | Lake Street | Buy |
| 2022-03-03 | Iniziato | Stifel | Buy |
Mostra tutto
Artivion Inc Borsa (AORT) Ultime notizie
Delray Medical Center is First Hospital in Palm Beach County to Perform Procedure Using AMDS™ Hybrid Prothesis Developed by Artivion Inc. - Florida Hospital News and Healthcare Report
Artivion Inc (AORT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Artivion Inc (AORT) Institutional Confidence - TradingKey
Artivion Inc (AORT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Artivion Inc (AORT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Artivion Inc (AORT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Artivion Inc (AORT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Artivion Inc (AORT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Artivion Inc (AORT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Artivion Inc (AORT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Artivion’s Andrew Green sells $910,738 in company stock - Investing.com UK
Artivion’s Andrew Green sells $910,738 in company stock By Investing.com - Investing.com India
Artivion Insider Sold Shares Worth $910,739, According to a Recent SEC Filing - marketscreener.com
Artivion (AORT) SVP exercises options and sells 44,001 shares under 10b5-1 plan - Stock Titan
Precision Trading with Artivion Inc Com (AORT) Risk Zones - Stock Traders Daily
AORT Q1 2026 Earnings: EPS Misses Estimates as Profitability Pressures EmergeAnalyst Coverage Count - The League of Women Voters of Texas
What Artivion (AORT)'s Strong Q1 Growth But Lowered Guidance Means For Shareholders - Yahoo Finance
Artivion secures FDA approval for NEXUS aortic arch system - MSN
[144] ARTIVION, INC. SEC Filing - Stock Titan
Will Stronger Revenue but Softer Outlook Change Artivion's (AORT) Growth-Quality Narrative? - simplywall.st
Artivion to present at 2026 Truist Securities MedTech Conference with live webcast on June 16 - Pluang
Artivion to Participate in the 2026 Truist Securities MedTech Conference - marketscreener.com
Cardiac surgery company Artivion joins 2026 Truist MedTech conference in Boston - Stock Titan
Analysts Offer Insights on Healthcare Companies: Artivion (AORT), Incyte (INCY) and ClearPoint Neuro (CLPT) - The Globe and Mail
Artivion (AORT) Stock Forum and Discussion - Moomoo
Artivion (AORT) Q1 2026 Earnings: Revenue Growth of 17.5% Meets Expectations Amid Mixed Industry Results - IndexBox
Q1 Earnings Outperformers: Artivion (NYSE:AORT) And The Rest Of The Medical Devices & SuppliesCardiology, Neurology, Vascular Stocks - Yahoo Finance
Lake Street Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $45 - Moomoo
Artivion (AORT) SVP discloses common stock, RSU and option holdings - Stock Titan
Estate move: Artivion (AORT) director moves 6,325 shares into trust - Stock Titan
Artivion, Inc. has exercised option to acquire Endospan Ltd. for approximately $380 million. - marketscreener.com
Artivion Inc. (AORT) Slips 0.76% as Stock Tests Key Support Near $19.85Hull Moving Average - thelegaladvocate.com
Artivion secures FDA approval for NEXUS aortic arch device, weighs Endospan acquisition - MSN
A Quick Look at Today's Ratings for Artivion(AORT.US), With a Forecast Between $36 to $48 - Moomoo
Stifel Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $45 - Moomoo
Stifel reiterates Artivion stock rating on surgeon survey results - Investing.com
Stifel reiterates Artivion stock rating on surgeon survey results By Investing.com - Investing.com South Africa
AORT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Artivion (AORT) Earnings Date and Reports 2026 $AORT - MarketBeat
Artivion Inc. (AORT) Holds Near Support as Mild Pullback Tests Recent RangeIchimoku TK Cross - thelegaladvocate.com
Artivion Inc. (AORT) Faces Selling Pressure as Shares Dip Below Key Moving AveragesTechnical Analysis - thelegaladvocate.com
Artivion Q1 earnings call highlights - MSN
AORT News | ARTIVION INC (NYSE:AORT) - ChartMill
Artivion (AORT) Q1 earnings and revenues surpass estimates - MSN
Artivion (AORT) director corrects details of restricted stock award - Stock Titan
Director at Artivion (NYSE: AORT) awarded 7,576 restricted shares - Stock Titan
Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System - MedTech Intelligence
Artivion (NYSE:AORT) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of - Yahoo Finance
Artivion (AORT) director receives 7,576-share equity RSA grant - Stock Titan
Artivion (AORT) director receives 7,850-share stock award, now holds 56,938 - Stock Titan
Artivion Earnings Call Balances Growth With Caution - TipRanks
Artivion Inc Azioni (AORT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):